These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 17927713)

  • 1. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
    Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
    Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation.
    Wang CH; Chen CL; Cheng KW; Huang CJ; Chen KH; Wang CC; Concejero AM; Cheng YF; Huang TL; Chiu KW; Wang SH; Lin CC; Liu YW; Jawan B
    Transplant Proc; 2008 Oct; 40(8):2489-91. PubMed ID: 18929775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron in the pathogenesis of hepatocellular carcinoma.
    Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
    Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D; Hebert B; Potti A
    Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron overload and cancer].
    Blanc JF; Bioulac-Sage P; Balabaud C
    Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance iron-free nodules in genetic hemochromatosis.
    Guyader D; Gandon Y; Sapey T; Turlin B; Mendler MH; Brissot P; Deugnier Y
    Am J Gastroenterol; 1999 Apr; 94(4):1083-6. PubMed ID: 10201487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population.
    Jaskiewicz K; Banach L; Lancaster E
    Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
    Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
    Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic iron overload and hepatocellular carcinoma.
    Kew MC
    Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.
    Crawford DH; Fletcher LM; Hubscher SG; Stuart KA; Gane E; Angus PW; Jeffrey GP; McCaughan GW; Kerlin P; Powell LW; Elias EE
    Hepatology; 2004 Jun; 39(6):1655-62. PubMed ID: 15185307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End stage liver disease in a 13-year old secondary to hepatitis C and hemochromatosis.
    Miller M; Crippin JS; Klintmalm G
    Am J Gastroenterol; 1996 Jul; 91(7):1427-9. PubMed ID: 8678008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron.
    Asare GA; Paterson AC; Kew MC; Khan S; Mossanda KS
    J Pathol; 2006 Jan; 208(1):82-90. PubMed ID: 16278820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of liver transplantation in hereditary hemochromatosis.
    Dar FS; Faraj W; Zaman MB; Bartlett A; Bomford A; O'Sullivan A; O'Grady J; Heneghan M; Rela M; Heaton ND
    Transpl Int; 2009 Jul; 22(7):717-24. PubMed ID: 19490544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
    Fargion S; Valenti L; Fracanzani AL
    Dig Liver Dis; 2011 Feb; 43(2):89-95. PubMed ID: 20739232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
    Gheorghe L; Iacob S; Bolog N; Stoicescu A; Pârvulescu I; Popescu I
    Rom J Gastroenterol; 2004 Mar; 13(1):33-8. PubMed ID: 15054524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.